Changchun High-Tech Industry Group Co (000661.SZ) Stock Price

Changchun High-Tech Industry Group Co Price

SZSE·CLOSED
73.77
​
Market closed

Over the last 19 years Changchun High-Tech Industry Group Co grew revenue by 17.3% annually, reaching 12.08 B CNY. Earnings per share have grown at 17.8% per year over the last 19 years. For Changchun High-Tech Industry Group Co, the net margin of 1.3% is down versus 35.0% a few years ago. At today's price the dividend yield works out to roughly 3.52%. The payout ratio is around 674% of earnings. The dividend has grown at 31.2% per year over the past 12 years. The consensus 12-month price target for Changchun High-Tech Industry Group Co is 128.53 CNY, about 74.2% above where the stock trades today. Of 9 analysts, 8 rate the stock a buy — an overall Buy consensus.

Changchun High-Tech Industry Group Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Changchun High-Tech Industry Group Co business model & stock analysis

Changchun High & New Technology Industries (Group), Inc. generates revenue through the research, development, production, and sale of biopharmaceuticals and proprietary Chinese medicines. Key products include polyethylene glycol recombinant human growth hormone injection, recombinant human growth hormone, recombinant human follicle stimulating hormone for injection, freeze-dried live attenuated varicella vaccines, and rabies vaccines for human use. The company also derives income from real estate development and property management services. Its primary market is domestic, serving customers within China who require pharmaceutical solutions and real estate services. The firm's biopharmaceutical segment focuses on innovative treatments such as growth hormone therapies and vaccines, targeting healthcare providers and consumers seeking advanced medical solutions. Real estate activities involve developing and managing properties, catering to residential and commercial clients in the domestic market. All operations are conducted within China, with no international expansion mentioned in the business description. Changchun High & New Technology Industries (Group), Inc. leverages its 8,841 full-time employees to support both pharmaceutical and real estate divisions. The company's product portfolio emphasizes high-demand medical treatments, including injectable growth hormones and vaccines, which are sold to domestic healthcare institutions and end-users. Real estate services complement the core business by providing additional revenue streams through property management and development.

Frequently asked questions about Changchun High-Tech Industry Group Co

Analysts currently set an average price target of 131.46 CNY for the Changchun High-Tech Industry Group Co stock (median: 128.53 CNY), implying +78.2 % versus the latest price. The consensus is based on 9 analyst ratings.

9 analysts currently rate the Changchun High-Tech Industry Group Co stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Changchun High-Tech Industry Group Co to generate revenue of 11.59 B CNY and earnings per share of 2.45 CNY.

Converted at the current exchange rate, the Changchun High-Tech Industry Group Co share trades at 9.91 EUR (73.77 CNY).

The Changchun High-Tech Industry Group Co share (000661.SZ) is listed on 1 stock exchanges, including: Shenzhen (000661.SZ).

The expected revenue of Changchun High-Tech Industry Group Co is 11.59 B CNY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Changchun High-Tech Industry Group Co is 983.06 M CNY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Changchun High-Tech Industry Group Co is currently 30.15. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Changchun High-Tech Industry Group Co stock.

The price-to-sales ratio (P/S) of Changchun High-Tech Industry Group Co is currently 2.56. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Changchun High-Tech Industry Group Co stock.

The Eulerpool Quality Score for Changchun High-Tech Industry Group Co is 3/10.

The ISIN of Changchun High-Tech Industry Group Co is CNE0000007J8. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Changchun High-Tech Industry Group Co is 000661.SZ. The ticker symbol is used to trade Changchun High-Tech Industry Group Co shares on the stock exchange.

Fair ValueTerminal
76.72 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
1.37 M CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website ccht.jl.cn
Country
Currency
CNY
Initial public offering
Dec 18, 1996
ISIN
CNE0000007J8
Cusip
Y1293Q109
Market capitalization
29.68 B CNYLarge Cap
52-Week Range
PEG
9.69
P/E ratio
P/Ee 2026
30.19
P/Ee 2027
22.22
P/Ee 2028
17.59
P/S
P/Se
2.56
EV/EBIT
33.04
P/B Ratio
1.35
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
0.67 %
Dividend
Dividend yield
3.52 %
Est. Dividend Yield
0.22 %
Payout Ratio
673.97 %
Dividend growth Ø5Y
-27.52 %
Dividend payments per year
1
Dividend paid since
13 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
10.00 %
Last updated Nov 9, 2026, 3:38 AM

Changchun High-Tech Industry Group Co Peer Group

Changchun High-Tech Industry Group Co Ticker

SHZ · 000661.SZ

Changchun High-Tech Industry Group Co FIGI

000661:CH · BBG000P65Q87000661:CS · BBG000P65QY8000661:C2 · BBG00F136DR4